EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
+5.4%/yr
Annual compound
5Y CAGR
+2.4%/yr
Consistent
Percentile
P86
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
4 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | 93.41% | +2.2% |
| 2024 | 91.42% | +1.7% |
| 2023 | 89.93% | +12.6% |
| 2022 | 79.89% | +2.6% |
| 2021 | 77.86% | -6.3% |
| 2020 | 83.09% | -4.3% |
| 2019 | 86.81% | +116.5% |
| 2018 | -524.86% | -624.9% |
| 2017 | 100.00% | +101.2% |
| 2016 | 49.69% | - |